AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated
that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

Aims The aim of this study was to test whether current and past night shift work was
associated with incident atrial fibrillation (AF) and whether this association was modified by …

Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Addressing
social determinants of health (SDoH) may be the next forefront of reducing the enormous …

Aims The aim of this study was to estimate the global burden of atrial fibrillation (AF)/atrial
flutter (AFL) and its attributable risk factors from 1990 to 2019. Methods and results The data …

Aims To estimate prevalence of atrial fibrillation (AF) in a representative sample of the Italian
elderly population, projecting figures for Italy and the European Union. Methods and results …